MSB partner JCR files for product approval
Filed with ASX · · 2 pages · English
Story so far
Earlier from Mesoblast
- Market Exclusivity Strengthened by New USA Healthcare Act
- Key Bone Repair Patent Granted in the United States
- TGA Approval To Commercially Manufacture Stem Cell Products
- Response to an ASX Price Query
- Positive Results From Phase 2 Lumbar Fusion Trial
Later from Mesoblast
- Mesoblast Cells Show Disease Modifying Effects on Knee OA
- Mesoblast Provides Q3 Financial Results and Corporate Update
- Mesoblast Receives $6.2m From Aus Govt For R&D
- Suspension from Official Quotation
- Update on Global Heart Failure Program
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast